rs367626762
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6
The NM_001164507.2(NEB):c.21797C>T(p.Pro7266Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000201 in 1,613,390 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P7266P) has been classified as Likely benign.
Frequency
Consequence
NM_001164507.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8 | c.21797C>T | p.Pro7266Leu | missense_variant | Exon 147 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
| NEB | ENST00000427231.7 | c.21797C>T | p.Pro7266Leu | missense_variant | Exon 147 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152186Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000218 AC: 54AN: 248072 AF XY: 0.000268 show subpopulations
GnomAD4 exome AF: 0.000200 AC: 292AN: 1461086Hom.: 0 Cov.: 30 AF XY: 0.000222 AC XY: 161AN XY: 726762 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000210 AC: 32AN: 152304Hom.: 1 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74462 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Uncertain:1Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
- -
Inborn genetic diseases Uncertain:1
The c.16694C>T (p.P5565L) alteration is located in exon 120 (coding exon 118) of the NEB gene. This alteration results from a C to T substitution at nucleotide position 16694, causing the proline (P) at amino acid position 5565 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Peripheral neuropathy Uncertain:1
- -
not provided Uncertain:1
- -
not specified Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Actin accumulation myopathy Other:1
Variant interpreted as Uncertain significance and reported on 03-18-2021 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at